This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thermo Fisher (TMO) Advances Customer Research With New Launch
by Zacks Equity Research
Thermo Fisher's (TMO) new instrument enables high-resolution images of nanoparticles and beam-sensitive materials to be obtained from a commercially available desktop SEM.
Thermo Fisher (TMO) to Meet Plasmid DNA Demand With New Facility
by Zacks Equity Research
Thermo Fisher's (TMO) new facility will manufacture materials that are essential for production of plasmid-based therapies and vaccines.
Thermo Fisher's (TMO) New Pact Drives Sustainable Lab Practices
by Zacks Equity Research
Thermo Fisher (TMO) expects to ACT label more than 1,200 additional SKUs to allow research, pharmaceutical and clinical laboratories to achieve their sustainability objectives.
Thermo Fisher's (TMO) Rapid DNA Solution Gets FBI Approval
by Zacks Equity Research
Thermo Fisher's (TMO) RapidHIT ID DNA Booking System allows seamless integration of Rapid DNA into the law enforcement booking agency process.
Thermo Fisher (TMO) Introduces CoE in Clinical Metabolomics
by Zacks Equity Research
Thermo Fisher's (TMO) new research collaboration is aimed to provide the metabolomics community with advanced, best practices and standard operating procedures.
The Zacks Analyst Blog Highlights: Salesforce, Thermo Fisher Scientific, Royal Dutch Shell, Citigroup and Starbucks
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Salesforce, Thermo Fisher Scientific, Royal Dutch Shell, Citigroup and Starbucks
Top Stock Reports for salesforce, Thermo Fisher & Royal Dutch Shell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including salesforce (CRM), Thermo Fisher Scientific (TMO), and Royal Dutch Shell (RDS.A).
Agilent (A) Expands Presence in LC Market With New Systems
by Zacks Equity Research
Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry.
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Thermo Fisher (TMO) Invites Applications for Oncomine Program
by Zacks Equity Research
Thermo Fisher (TMO) to review research proposals eligible for the Oncomine Clinical Research Grant program.
Thermo Fisher's (TMO) New Launch Boosts Preclinical Development
by Zacks Equity Research
Thermo Fisher's (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.
Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases Drop
by Zacks Equity Research
In academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally.
4 Stocks to Watch in the Growing Nanotechnology Market
by Kaustav Ghosh
Watch out for names like Onto Innovation (ONTO), DuPont de Nemours (DD), Thermo Fisher Scientific (TMO) and International Business Machines (IBM) as the nanotechnology market continues to grow.
The Zacks Analyst Blog Highlights: JPMorgan, PayPal, Thermo Fisher Scientific, PepsiCo, McDonald's and Canadian National Railway
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, PayPal, Thermo Fisher Scientific, PepsiCo, McDonald's and Canadian National Railway
Top Analyst Reports for JPMorgan, PayPal & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), PayPal (PYPL), and Thermo Fisher Scientific (TMO).
3 Medical Diagnostics Stocks in Focus on Long-Term Potential
by Riya Anand
MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.
Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $445.33 in the latest trading session, marking a -0.86% move from the prior day.
Moderna (MRNA) Files for Full Approval of COVID-19 Vaccine
by Zacks Equity Research
Moderna (MRNA) seeks full approval for its COVID-19 vaccine, mRNA-1273, in adults with initiation of rolling submission of a BLA. The company also boosts manufacturing capacity for the vaccine.
LabCorp (LH) New Study Looks at COVID-19 Antibody Longevity
by Zacks Equity Research
LabCorp (LH) claims this to be the largest known COVID-related study in terms of specimen volume.
Thermo Fisher's (TMO) New Alliance Boosts Electron Microscopy
by Zacks Equity Research
This instrument by Thermo Fisher (TMO) is set to play a vital role in developing advanced solar cells, transport alloys, battery materials, low-energy electronics, catalysts and biodegradable polymers.
Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal
by Zacks Equity Research
Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.
The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev
Top Stock Reports for UnitedHealth, PayPal & NextEra
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), PayPal (PYPL), and NextEra (NEE).
Healthcare ETFs on Radar As Q1 Earnings Unfold
by Sweta Killa
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.